Interventional firm Guidant has signed a definitive agreement to acquire X Technologies, a privately held corporation based in Tustin, CA, and Yavne, Israel. The firm manufactures the FX miniRail, a coronary device for the treatment of de novo lesions and in-stent restenosis.
The product, comprised of two metal wires external to an angioplasty balloon, received CE Mark approval in December 2001 and is currently available in Europe, Asia Pacific, the Middle East, and Africa. A pre-market approval submission for the device was filed with the U.S. Food and Drug Administration in September 2002.
In other news, the firm has named Dana Mead Jr., its current vice president of corporate relations and policy, to the post of president, vascular intervention. Mead replaces John Capek, who has accepted a position leading a new business venture affiliated with Guidant, according to Indianapolis-based company.
By AuntMinnie.com staff writersMarch 11, 2003
Related Reading
Guidant posts record 2002, January 30, 2003
Guidant/Cook deal in doubt, January 3, 2003
Guidant gets CE Mark for stent system, December 19, 2002
Guidant sees record third quarter, October 17, 2002
Guidant to buy Cook, July 30, 2002
Copyright © 2003 AuntMinnie.com
